<DOC>
	<DOCNO>NCT02399839</DOCNO>
	<brief_summary>To evaluate outcome pregnancy woman treat lomitapide .</brief_summary>
	<brief_title>Global Lomitapide Pregnancy Exposure Registry</brief_title>
	<detailed_description>To evaluate outcome pregnancy woman treat lomitapide time within 30 day prior first day Last Menstrual Period ( LMP ) pregnancy . The outcomes primary interest major congenital anomaly .</detailed_description>
	<criteria>Pregnant female expose lomitapide time within 30 day prior first day LMP pregnancy . Patients unable unwilling provide write informed consent assent eligible participate PER .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>